Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

292 results about "Lactococcus lactis subsp. lactis" patented technology

Bacillus licheniformis SCWLY202405 and application thereof

The invention provides bacillus licheniformis SCWLY202405 and application thereof, the bacillus licheniformis SCWLY202405 is preserved in China Center for Type Culture Collection on May 15, 2024, the preservation address is Wuhan University, Wuhan, China, and the preservation number is CCTCC NO: M2024931. The strain can generate biological inhibition and regulation effects on staphylococcus, enterobacter cloacae, klebsiella pneumoniae, lactococcus lactis, lactobacillus lactis and Weissella in the yeast making fermentation process of Daqu, and metabolizes high-content flavor compounds such as acetoin, guaiacol and p-vinyl guaiacol.
Owner:GUIZHOU UNIV

Bacterial strain with purine reducing function and application thereof

The invention belongs to the technical field of functional microorganism screening and application, and particularly relates to a strain with a purine reducing function and application thereof. The lactococcus lactis AMCC 11671 (Lactococcus lactis AMCC 11671) provided by the invention is preserved in the China Center for Type Culture Collection (CCTCC), and the preservation number of the lactococcus lactis AMCC 11671 is CCTCC NO: M 2024078. The lactococcus lactis AMCC 11671 provided by the invention has good crude enzyme activity, can effectively slow down the generation and accumulation of uric acid by reducing the purine content and degrading uric acid, has good tolerance to acid and cholate, has the ability to tolerate gastrointestinal tract environment, and has potential of colonization in human gastrointestinal tracts and play roles.
Owner:ANGEL YEAST (LIUZHOU) CO LTD +1

Lactococcus lactis subsp. Lactis and application thereof in fermentation of periplaneta americana powder

The invention discloses lactococcus lactis subsp. Lactis and application thereof in fermentation of American cockroach powder. The strain is separated and screened from the intestinal contents of the Amolops nobilis, grows well on an MRS agar culture medium, is not hemolyzed, is sensitive to various common antibiotics, has relatively strong adaptive capacity to the intestinal environment of human and animals, has relatively strong lactic acid production capacity, and has strong inhibition capacity to common intestinal pathogens of human and animals. When the strain is used for fermenting American cockroach powder, the content of bioactive substances such as amino acids, peptides, indoles, pyrimidine and purines can be greatly increased, fermented sterile supernate has an obvious effect on mouse colitis induced by DSS, and the inflammatory factor level is remarkably reduced; the strain opens up a new way for further development and utilization of the traditional Chinese medicinal material periplaneta americana.
Owner:SICHUAN UNIV

Complex microbial inoculant, original cheese, processed cheese with function of reducing blood sugar and preparation and application of complex microbial inoculant

The invention belongs to the field of fermentation, and particularly relates to a complex microbial inoculant, original cheese, processed cheese with a blood sugar reducing function and preparation and application of the complex microbial inoculant. Wherein the processed cheese is prepared by the method comprising the following steps: mixing the components including raw cheese, sugarcane juice, corn oil, casein, concentrated milk protein, blueberry powder, mono / diglycerol fatty acid ester, sodium citrate, sodium tripolyphosphate, sodium hexametaphosphate, salt guar gum, potassium sorbate and water, and then emulsifying to obtain the processed cheese, the sugar cane juice, the corn oil, the casein, the concentrated milk protein, the blueberry powder, the mono / diglycerol fatty acid ester, the sodium citrate, the sodium tripolyphosphate, the sodium hexametaphosphate, the salt guar gum, the potassium sorbate and the water, the original cheese is prepared from a complex microbial inoculant, and the complex microbial inoculant comprises lactococcus lactis bacterial powder, lactococcus lactis subsp. Lactis bacterial powder, lactobacillus delbrueckii subsp. Lactis bacterial powder, lactobacillus plantarum bacterial powder and lactobacillus paracasei bacterial powder. The processed cheese provided by the invention has a better function of controlling blood sugar, and meanwhile, the processed cheese is fine and uniform in texture and has good smearing performance.
Owner:YICHANG XIWANG FOOD CO LTD +1

Preparation method of glucose fermentation product with bacteriostatic activity

The invention relates to the technical field of microbial fermentation, in particular to a preparation method of a glucose fermentation product with bacteriostatic activity, which comprises the following steps: (1) inoculating a lactococcus lactis subsp. Lactis seed solution into a glucose-containing fermentation culture solution, and fermenting to obtain a first fermentation solution; (2) inoculating a pediococcus acidilactici seed solution into the first fermentation liquor, supplementing glucose, and fermenting to obtain second fermentation liquor; and (3) adjusting the pH value of the second fermentation liquor to be acidic, filtering, concentrating, and spray-drying to obtain the glucose fermentation product. According to the invention, the characteristic that organic acids and bacteriocin generated by lactococcus lactis subsp. Lactis and pediococcus acidilactici are different in types is fully utilized, metabolites of the two bacteria are obtained at the same time by adopting a sequential sequence type fermentation mode, and the metabolites of the lactococcus lactis subsp. Lactis are converted by pediococcus acidilactici, so that a new substance with bacteriostatic activity is obtained; the antibacterial activity is improved. Meanwhile, the problem of nutrition competition caused by mixed culture of the two bacteria is avoided, and the fermentation efficiency is improved.
Owner:YOTA BIO-ENG CO LTD

Lactococcus lactis subsp. Lactis JYLL-51 for improving sarcopenia obesity as well as fungicide and application of lactococcus lactis subsp. Lactis JYLL-51

The invention relates to the technical field of microorganisms, in particular to lactococcus lactis subsp. Lactis JYLL-51 for improving sarcopenia obesity as well as a microbial agent and application of the lactococcus lactis subsp. Lactis JYLL-51. The Lactococcus lactis subsp. Lactis JYLL-51 is preserved in China General Microbiological Culture Collection Center (CGMCC) on March 13, 2024, the preservation address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number is CGMCC NO.30016. The Lactococcus lactis subsp. Lactis JYLL-51 has the advantages that the Lactococcus lactis subsp. Lactis JYLL-51 can be used for preparing the Lactococcus lactis subsp. Lactis JYLL-51; the invention provides a lactococcus lactis subsp. Lactis JYLL-51, and experiments show that the lactococcus lactis subsp. Lactis JYLL-51 microbial inoculum prepared from the strain can not only improve the weight and strength of skeletal muscle, but also reduce fat accumulation induced by high fat, and can significantly improve sarcopenia obesity.
Owner:MINSHENG ZHONGKE JIAYI (SHANDONG) BIOTECHNOLOGY CO LTD

Method for fermenting cacumen biotae with compound bacteria and application

The invention relates to the field of biological fermentation, in particular to a method for fermenting cacumen biotae with compound bacteria and application of the cacumen biotae, and the compound bacteria comprise lactococcus lactis and pichia pastoris. The method comprises the following steps: (1) pretreating cacumen biotae; (2) performing enzyme treatment on the cacumen biotae; (3) fermenting the cacumen biotae; and (4) treating fermentation liquor. The invention has the following beneficial effects: (1) enzymolysis parameters are optimized, fermentation parameters are optimized, a fermentation liquor extraction method is optimized, and a better fermentation method is obtained; (2) the Chinese arborvitae twigs are fermented, so that compared with fermentation of various traditional Chinese medicine raw materials in the prior art, the components are simplified, and the method is more convenient; and (3) a mouse experiment proves that more flavones and a better anti-hair loss effect can be obtained by using the optimized fermentation method, and the application of the cacumen biotae is more facilitated.
Owner:YUNBIN (SHANGHAI) HEALTH TECH CO LTD

Mutant strain with high yield of nisin and application of mutant strain

The invention belongs to the technical field of microorganism mutation breeding, and particularly relates to a nisin high-yield mutant strain with enhanced production performance. The mutant strain is specifically lactococcus lactis 2686, and the preservation number of the mutant strain is CCTCC (China Center for Type Culture Collection) NO: M 2023219. The strain has relatively high osmotic pressure tolerance, can still normally grow and produce nisin when the osmotic pressure is higher than 0.66 osM / kg H2O, meanwhile, the strain has excellent nisin production capacity, the titer reaches 9834 IU / mL when the strain is fermented in a shake flask for 21 hours, and the titer reaches 21000 IU / mL when the strain is fermented in a fermentation tank for 22 hours. The method is high in yield, good in stability, low in production cost and suitable for further industrial application.
Owner:ZHEJIANG SILVER ELEPHANT BIO ENG

Lactococcus lactis subsp. Lactis VB346 capable of efficiently degrading purine and application thereof

The invention relates to the field of microorganisms, and discloses a Lactococcus lactis subsp. Lactis VB346 which is preserved in the China Center for Type Culture Collection on September 20, 2024, and the preservation number is CCTCC NO: M 20242013. The invention further discloses a preparation method of the Lactococcus lactis subsp. Lactis VB346. The lactococcus lactis subsp. Lactis VB346 disclosed by the invention has the capability of efficiently degrading purine nucleoside, and can decompose purine nucleoside in ingested food in intestinal tracts, so that the absorption amount of purine nucleoside by small intestines is reduced. The polypeptide has the ability of degrading bilirubin, and can be used for treating or improving hyperbilirubinemia, or improving liver and gall injury caused by hyperbilirubin; meanwhile, the acid resistance required by survival in the stomach, the cholate tolerance required by survival in the intestinal tract and the stable survival ability in the intestinal tract are achieved, and the bacillus subtilis has huge application prospects in preparation of drugs, microbial agents, health care products or food.
Owner:HANGZHOU VICROBX BIOTECH CO LTD

Lactococcus lactis HX21473 and application thereof

The invention belongs to the technical field of biological medicine, and discloses lactococcus lactis HX21473 and application thereof, the lactococcus lactis HX21473 is preserved in China General Microbiological Culture Collection Center (CGMCC) on January 20, 2025, and the preservation number is CGMCC NO.33476. The invention further discloses a preparation method of the lactococcus lactis HX21473. The invention provides a strain of lactococcus lactis HX21473 capable of efficiently expressing a foreign protein. The lactococcus lactis HX21473 has strong acid resistance, can be used as an oral vaccine live carrier, and promotes research, development and application of oral vaccines.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Preparation method of bamboo-based hard carbon sodium ion battery negative electrode material

The invention belongs to the technical field of new energy materials, and particularly relates to a preparation method of a bamboo-based hard carbon sodium ion battery negative electrode material, which specifically comprises the following steps: (1) slicing, crushing, screening, sieving, drying and treating fresh bamboo under steam pressure to obtain bamboo powder; (2) bamboo powder and lactococcus lactis liquid are mixed and fermented, and after fermentation is completed, the bamboo powder and the lactococcus lactis liquid are washed to be neutral and dried; (3) placing the bamboo powder subjected to fermentation treatment in an inert atmosphere, heating, keeping constant temperature, and cooling to obtain a pre-carbonized sample; (4) soaking the pre-carbonized sample in a hydrochloric acid solution, continuously reacting, washing to be neutral, and drying; and (5) continuously heating the acid-washed and dried material in the step (4) in the inert atmosphere, carbonizing at a constant temperature, and cooling to obtain the final sodium-ion battery negative electrode material. The method disclosed by the invention has the advantages of remarkable environmental friendliness, low cost, simplicity and convenience in operation and the like; and the battery negative electrode material prepared by the method disclosed by the invention has excellent electrochemical performance.
Owner:QUZHOU RES INST OF ZHEJIANG UNIV

Method for rearing fries of Epinephelus lanceolatus

The invention belongs to the technical field of aquaculture, and particularly relates to a pearl grouper fry rearing method. According to the method, firstly, after the roes are hatched, the fries are soaked with a bactericide, harmful bacteria on the surfaces of the roes and in a hatching pond can be effectively killed, and a bacteria solution of lactobacillus brevis serves as the bactericide, so that the use of antibiotics is reduced while the growth of pathogenic bacteria is inhibited; the culture pond is divided into 1m * 1m spaces by the partition plates, so that the phenomenon that the fries kill each other or snatch for food due to insufficient spaces is avoided, and uniform growth of the fries is facilitated; culture is carried out in stages according to nutritional requirements of different growth stages, and the Weissella microbial inoculum and the lactococcus lactis microbial inoculum are added to the feed in each stage, so that the intestinal microecological balance of the fry is adjusted, the growth and reproduction of harmful bacteria are inhibited, the intestinal digestion and absorption functions of the fry are enhanced, and the utilization rate of the feed is increased.
Owner:GUANGDONG DALINYANG MARINE BIOLOGICAL CO LTD

A weight-reducing traditional Chinese medicine composition and a preparation method thereof

The present application relates to the technical field of traditional Chinese medicine, in particular to a kind of slimming traditional Chinese medicine composition and preparation method thereof.The present application uses the raw materials such as Buzha Leaf, hawthorn, lotus leaf, immature fruit of Chinese citron, magnolia officinalis, raphanus sativus, dried orange peel, pellitory, alisma orientalis and cassia obtusifolia, after decoction, lactic acid lactobacillus lactis CICC 6242 and royi mucous lactobacillus CICC 6121 are fermented with 0.4-0.8:1 ratio, then combined enzymolysis is carried out using ginger protease and snail protease, and then 15-25wt% ethanol is used for extraction, and the composition is endowed with excellent lipid-lowering and weight loss effect.
Owner:GUANGZHOU TONGSHANCHANG BIOTECHNOLOGY CO LTD

Lactococcus lactis Jlus 880314 and application thereof

The invention belongs to the field of microorganisms, and particularly relates to lactococcus lactis Jlus 880314 and application thereof. The strain is classified and named as Lactococcus lactis, and is preserved in the China General Microbiological Culture Collection Center (CGMCC), and the preservation address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing; the preservation number of the strain is CGMCC No. 33961. Time-of-flight mass spectrometry analysis shows that nisin exists in a metabolite of the strain, and the strain can be used for producing nisin. The compound shows an excellent and wide antibacterial function in antibacterial experiments, can be used for preparing antibacterial drugs, particularly has a remarkable inhibiting effect on growth of gram-negative bacteria and fungi, can be used for preparing drugs for relieving or treating enteritis, or preparing drugs, nourishment or health care products for regulating gastrointestinal tract micro-ecological balance of people or animals, and can be used for preparing medicines for relieving or treating enteritis. The compound can also be used for preparing antibacterial food additives and / or animal feed additives. A hemolysis experiment result shows that hemolysis is avoided, toxic and side effects are small, and wide development prospects and application values are achieved.
Owner:JILIN UNIVERSITY +1

Yoghourt oil with fruity flavor and preparation method thereof

The invention discloses yoghurt oil with fruity flavor and a preparation method of the yoghurt oil, and belongs to the technical field of yoghurt oil processing. The Lactococcus lactis SITRS-0011 provided by the invention can be independently used as a leavening agent, when the Lactococcus lactis SITRS-0011 is used for fermenting yoghurt oil, the titration acidity can reach 83.21 DEG T, the yoghurt oil contains 2, 3-butanedione (1180 [mu] g / kg), acetoin (2092 [mu] g / kg), lactones (623 [mu] g / kg), 3-methylbutyraldehyde (117 [mu] g / kg), phenethyl alcohol (1863 [mu] g / kg), phenylacetaldehyde (336 [mu] g / kg) and other substances, and the Lactococcus lactis SITRS-0011 is rich in milk flavor, has flower fragrance and nut flavor, is unique in flavor, and can be used for preparing the and the overall sensory score is high.
Owner:SHANGHAI INST OF TECH

Lactococcus lactis strain with high nisin yield and application

The invention discloses a lactococcus lactis strain with high nisin yield and application, and belongs to the technical field of industrial microorganisms. According to the invention, a nisin-tolerant nisin high-producing strain (Lactococcus lactis MN6) is successfully bred on the basis of compound mutation of ethyl methane sulfonate and heavy ion beam and in combination with nisin resistance screening, the strain can tolerate a fermentation environment with the nisin concentration of 6000 IU. ML <-1 >, the nisin yield through shake flask horizontal fermentation can reach 10776 IU. ML <-1 >, which is 9.76 times of the shake flask fermentation yield of original bacteria, the strain has good passage stability, and the strain can be used for producing a high-yield strain of nisin. The method is more suitable for industrial production.
Owner:JIANGNAN UNIV

Lactococcus lactis recombinant bacterium for expressing cyclic diadenylate and application of lactococcus lactis recombinant bacterium

The invention discloses a lactococcus lactis recombinant bacterium for expressing cyclic diadenylate and application of the lactococcus lactis recombinant bacterium. Homologous DAC is introduced into lactococcus lactis NZ9000, PDE is knocked out to improve expression of cyclic diadenylate in lactic acid bacteria, and meanwhile, the yield of a cyclic diadenylate precursor ATP is increased by increasing the expression quantity of glycolysis key enzyme PFK; and the ldh gene is knocked out to reduce the accumulation of byproducts, so that the yield of the inner ring diadenylate of the lactic acid bacteria is further improved.
Owner:SHANDONG CANDERAY AGRI SCI & TECH CO LTD +1

Preparation method of novel PEDV (porcine epidemic diarrhea virus) subunit vaccine

The invention provides a preparation method of a novel PEDV (porcine epidemic diarrhea virus) subunit vaccine, and belongs to the technical field of biology. The novel PEDV subunit vaccine is prepared by adopting a method comprising the following steps: (1) treating lactococcus lactis by using a high-pressure damp-heat method to obtain peptidoglycan particles; (2) treating the peptidoglycan particles by adopting an ultrahigh-pressure microjet technology to obtain a peptidoglycan carrier with the particle size of 280-850nm; and (3) mixing the peptidoglycan carrier with a PEDV subunit antigen of which the amino acid sequence is SEQ ID NO: 1 to obtain the novel PEDV subunit vaccine. The novel PEDV subunit vaccine comprises a peptidoglycan carrier with a specific size, can improve the in-vivo presentation efficiency of an antigen and rapidly induce efficient body fluid and mucous membrane immune response, and is of great significance to research and development of vaccines for porcine epidemic diarrhea diseases and the like.
Owner:JIANGSU ACAD OF AGRI SCI +1

Polypeptide for promoting exocrine expression of target protein, biological material and application thereof, antibacterial peptide fusion protein and recombinant genetic engineering bacterium

The invention belongs to the technical field of biological genetic engineering, and particularly relates to a polypeptide for promoting exocrine expression of a target protein, a biological material and application thereof, an antibacterial peptide fusion protein and a recombinant genetic engineering bacterium. As a signal peptide, the polypeptide provided by the invention further improves the exocrine expression efficiency and yield of the target protein; a contrast experiment verifies that compared with the existing signal peptide, the optimized and modified signal peptide has the advantage that the efficiency of exocrine expression of target protein of a constructed lactococcus lactis expression system is improved by 2.1-13.6 times. The recombinant genetically engineered bacterium constructed by the invention successfully realizes efficient exocrine expression of the antibacterial peptide by the lactococcus lactis, has the probiotic property of lactic acid bacteria and the antibacterial effect of the antibacterial peptide, can be directly orally taken or used as an additive to be applied to food and animal feed, and greatly saves the production and preparation cost of the antibacterial peptide.
Owner:HENAN INST OF SCI & TECH

Postbiotic composition for effectively inhibiting dental caries in oral cavity and preparation method thereof

The invention belongs to the technical field of biomedical treatment and biological fermentation, discloses a metagen composition for effectively inhibiting oral dental caries and application thereof, and aims to solve the problems of great side effect, weak effect and unknown mechanism of the existing dental caries prevention and treatment means. The composition is prepared by mixing a metagen 1 which is prepared by fermenting lactobacillus salivarius Postbio-YY with a metagen 2 which is prepared by fermenting lactococcus lactis Postbio-F3 and lactobacillus paracasei Postbio-P6 step by step. In the preparation process, the active ingredients are reserved by accurately controlling the fermentation pH, time and pasteurization parameters. The composition can be prepared into multiple dosage forms such as toothpaste and the like, can remarkably inhibit the growth of streptococcus mutans and destroy the thallus structure, inhibits biofilm and exopolysaccharide synthesis by down-regulating fimI, wcaJ and wcae genes, is safe and free of side effects, and provides an efficient scheme for decayed tooth prevention and treatment.
Owner:YANGZHOU PERFECT DAILY CHEM

Bifidobacterium-containing fermented milk with good microrheology property and preparation method thereof

PendingCN119257163AEnhanced microrheological characteristicsImprove sensory qualityMilk preparationFood processingBiotechnologyMicroorganism
The invention relates to the technical field of probiotic leavening agents, in particular to fermented milk containing bifidobacteria with good microrheology characteristics and a preparation method of the fermented milk. The probiotic leavening agent provided by the invention is composed of an auxiliary leavening agent, a basic leavening agent and active probiotics, the auxiliary leavening agent is prepared from lactococcus lactis IMAU11823 (preserved in China General Microbiological Culture Collection Center, with the preservation number of CGMCC 16243), and the basic leavening agent is prepared from lactococcus lactis IMAU11823 (preserved in China General Microbiological Culture Collection Center, with the preservation number of CGMCC 16243). The active probiotic fermentation agent is prepared from bifidobacterium animalis subsp. Lactis Cai-4 (preserved in China General Microbiological Culture Collection Center (CGMCC), and the preservation number is CGMCC No.31691), and the fermentation agent matrix is milk.
Owner:INNER MONGOLIA AGRICULTURAL UNIVERSITY +1

Method for reducing biogenic amine in air-dried goose product through combination of pulsed electric field and inoculation fermentation

The invention discloses a method for reducing biogenic amine in an air-dried goose product by combining a pulsed electric field with inoculation fermentation, which is characterized by comprising the following steps: treating fresh goose meat at 0.5-1kv / cm for 50-180s, pickling the goose meat in a 8wt% sodium chloride solution for 24h, hanging the pickled goose meat in an air dryer for 1h, draining off water, and drying the goose meat in the air dryer to obtain dried goose meat; the method comprises the following steps: uniformly spraying a compound bacterial solution consisting of lactobacillus plantarum pdd-1 and lactococcus lactis according to the inoculation amount of 1 * 10 < 5 >-1 * 10 < 7 > CFU / mL, and air-drying for 3-5 days at 10-20 DEG C to obtain the air-dried goose product with low biogenic amine, which has the advantages of obviously reducing the content and variety of biogenic amine, inhibiting the degradation of protein in the air-dried goose and obviously increasing flavor substances.
Owner:NINGBO UNIV +1

Application of lactococcus lactis in product for improving sleep

The invention relates to the field of microorganisms, and discloses application of lactococcus lactis in a product for improving sleep. The lactococcus lactis is named as WHH2078, is separated from yoghurt butter collected from a country in Sankarst city in Tibet Autonomous Region in China, is preserved in China General Microbiological Culture Collection Center on February 25, 2021, has a preservation number of CGMCCNO.21831, and is classified and named as Lactococcus lactis. The Lactococcus lactis is named as Lactococcus lactis, and the Lactococcus lactis is named as Lactococcus lactis. The lactococcus lactis has the effects of shortening the sleep latency, prolonging the total sleep time, improving 5-hydroxytryptamine and gamma-aminobutyric acid of the brain, serum and colon, lowering the corticosterone level, regulating back the diversity of intestinal microorganisms alpha, regulating up the abundance of intestinal acidobacilli and lowering the abundance of actinomycetes, desulfurization bacilli and verruca microflora. The sleep disorder can be effectively improved.
Owner:HANGZHOU WAHAHA TECH

Lactococcus lactis M6 and application thereof

The invention discloses lactococcus lactis M6 and application thereof, and belongs to the technical field of microorganisms. The lactococcus lactis M6 provided by the invention is obtained by separating and purifying a kiwi fruit sample picked in Sichuan of China, has multiple functions of high yield of gamma-aminobutyric acid (GABA), high yield of butyric acid, oxidation resistance, antibacterial performance and the like, and has great industrial application value.
Owner:SICHUAN CHENGDU CENT AGRI UNIV MODERN AGRI IND RES INST

Strain having activity of reducing advanced glycation end products and use thereof

The present invention relates to a novel strain having the activity of reducing advanced glycation end products and a use thereof and, more particularly, to a food composition having the activity of reducing advanced glycation end products and a pharmaceutical composition for preventing or treating a disease caused by advanced glycation end products each of which comprises a Lactococcus lactis KF140 (accession number KCCM11673P) strain, a Bacillus subtilis KF11 (accession number KCCM11981P) strain, a Lactobacillus pentosus KF8 (accession number KCCM11997P) strain, or a Lactobacillus paracasei KF00816 (accession number KCCM11998P) strain, which are all novel strains; a lysate thereof; or a culture thereof as an active ingredient. In addition, the present invention relates to a composition for intestinal regulation, a probiotic composition, a feed composition, and a fermented product, each of which comprises the novel strain of the present invention, a lysate thereof, or a culture thereof as an active ingredient.
Owner:KOREA FOOD RES INST

Biological preparation for relieving intestinal discomfort caused by alcohol as well as preparation method and application of biological preparation

The invention relates to the technical field of functional microbial preparations, in particular to a biological preparation for relieving intestinal discomfort caused by alcohol and a preparation method and application thereof.The main technical scheme is that the biological preparation is prepared from, by weight, 5-20 parts of bacillus coagulans, 10-30 parts of pediococcus pentosaceus, 5-10 parts of lactobacillus rhamnosus and 0-20 parts of saccharomycetes. 0-5 parts of bifidobacterium longum and 0-5 parts of lactococcus lactis. By constructing an alcohol metabolism-intestinal protection dual-function synergistic system, specific florae such as bacillus coagulans, pediococcus pentosaceus and lactobacillus rhamnosus are scientifically compatible with functional components such as inulin and L-cysteine, alcohol is efficiently metabolized, and a carbon source is generated; the technical problems of low metabolic efficiency, weak intestinal protection and serious gastric acid inactivation of a traditional product are comprehensively solved.
Owner:CHANGZHOU AISIKANG BIOMEDICAL CO LTD

High-protein vinasse fermented feed

The invention discloses a high-protein vinasse fermented feed which is prepared by taking 60-80% of vinasse and 20-40% of an auxiliary material as raw materials, inoculating a bacillus licheniformis bacterial liquid, a candida utilis bacterial liquid, a lactococcus lactis bacterial liquid and a lactobacillus salivarius bacterial liquid and fermenting, and the auxiliary material is prepared by mixing rumex hanus and broken rice according to a mass ratio of 2: 1; experimental results show that compared with a mixture before fermentation, the fermented vinasse mixed feed has the advantages that the crude protein improvement rate can reach 19-21%, and meanwhile, acidic and neutral detergent fibers, zearalenone toxin, aflatoxin and vomitoxin can be effectively reduced. The strains used in the method are probiotics, and the biological fermentation feed not only can improve the utilization rate of feed raw materials, but also can inhibit the reproduction of harmful bacteria in animal intestinal tracts, promote the health of the animal intestinal tracts and improve the animal immunity.
Owner:KUNMING UNIV OF SCI & TECH

Lactococcus lactis carrier oral vaccine for enterotoxigenic escherichia coli F18 fimbriae and application of lactococcus lactis carrier oral vaccine

ActiveCN120392992AAntibacterial agentsBacteriaStaphylococcus lactisAntigen surface
The invention belongs to the technical field of biological genetic engineering, and discloses a lactococcus lactis carrier oral vaccine for enterotoxigenic escherichia coli F18 fimbriae and application. Four lactococcus lactis antigen surface display strains are prepared and are mixed for oral immunization. The oral immunization mode is convenient to operate, the stress reaction of injection immunization to animals is avoided, meanwhile, the immunization effect is greatly improved, and diarrhea of enterotoxigenic escherichia coli to piglets can be effectively prevented. The escherichia coli vaccine is an oral escherichia coli vaccine, a mouse immune challenge experiment shows that the vaccine can be completely survived under the challenge dosage of LD50, a piglet immune challenge experiment shows that the diarrhea condition of piglets can be completely protected, and it is indicated that an immune group generates effective mucosal immune protection capacity.
Owner:HUAZHONG AGRI UNIV

Yoghourt as well as preparation method and application thereof

The invention relates to the technical field of food, and particularly discloses yoghourt as well as a preparation method and application thereof. The invention provides a preparation method of yoghurt, the yoghurt is prepared by fermenting a substrate through zymophyte, the substrate comprises a milk base material and protease, and the milk base material comprises concentrated animal milk and a fat raw material; the milk base material is subjected to lipase enzymolysis before fermentation and then is used for fermentation; the protease comprises flavourzyme or further comprises neutral protease; the fat raw material comprises one or more of cream cheese, fermented butter and single cream; the zymophyte is composed of lactobacillus helveticus, lactococcus lactis subsp. Lactis (diacetyl type), lactococcus lactis subsp. Cremoris, streptococcus salivarius subsp. Thermophilus and lactobacillus delbrueckii subsp. Bulgaricus. The content of flavor substances in the yoghourt can be increased, and the quality of the yoghourt is improved.
Owner:INNER MONGOLIA MENGNIU DAIRY IND (GROUP) CO LTD

Health-care composition containing microbial beneficial bacteria and preparation method of health-care composition

The invention relates to the technical field of health-care food, and discloses a health-care composition containing microbial beneficial bacteria and a preparation method of the health-care composition. Comprising the following components in parts by weight: 30-40 parts of gelatinized starch, 8-15 parts of plant enzyme powder, 2-10 parts of microcapsule compound beneficial bacteria, 3-5 parts of selenium-enriched yeast powder, 0.5-2 parts of an American ginseng extract, 12-20 parts of fructo-oligosaccharide, 1-2.5 parts of curcumin, 7-9 parts of ovalbumin and 5-8 parts of sodium carboxymethyl cellulose. Microcapsule composite beneficial bacteria are prepared by compounding bifidobacterium longum, lactobacillus acidophilus, lactobacillus rhamnosus and lactococcus lactis, bridging with carboxymethylated beta-glucan and a Fe < 3 + >-polyphenol network structure and embedding with a protein-polysaccharide system, and can stably exist in an environment with strong acid and high-concentration bile salt to gastrointestinal tracts; through the synergistic effect of different nutrient substances, the intestinal microbe balance can be improved, and the immunity can be remarkably improved.
Owner:GANSU YOUTH PHARMACEUTICAL CO LTD